X4 Pharmaceuticals (XFOR) PT Lowered to $10 at Stifel
Tweet
Share
E-mailGet Alerts XFOR Hot Sheet
Price: $4.04 --0%
Rating Summary:
13 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 44
Rating Summary:
13 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 44
Join SI Premium – FREE
Stifel analyst Stephen Willey lowered the price target on X4 Pharmaceuticals (NASDAQ: XFOR) to $10.00 (from $18.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocMorris AG (DOCM:SW) PT Raised to CHF12.50 at Deutsche Bank
- Barclays Downgrades Merlin Properties SA (MRL:SM) (MRPRF) to Equalweight
- Humana (HUM) PT Raised to $450 at Wolfe Research
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
